2NS5

The conserved N-terminal domain of Par-3 adopts a novel PB1-like structure required for Par-3 oligomerization and apical membrane localization

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1mM unlabelled Par3 V13D NTD; 100mM sodium chloride; 99.9% D2O	99.9% D2O	100mM sodium chloride	7.0	1 atm	303
2	3D_15N-separated_NOESY	1mM uniformly 15N labelled Par3 V13D NTD; 100mM sodium chloride; 90% H2O, 10% D2O	90% H2O/10% D2O	100mM sodium chloride	7.0	1 atm	303
3	HNCO, HNCACB, CBCA(CO)NH	1mM uniformly 15N/13C labelled Par3 V13D NTD; 100mM sodium chloride; 90% H2O, 10% D2O	90% H2O/10% D2O	100mM sodium chloride	7.0	1 atm	303
4	3D_13C-separated_NOESY	1mM uniformly 15N/13C labelled Par3 V13D NTD; 100mM sodium chloride; 99.9% D2O	99.9% D2O	100mM sodium chloride	7.0	1 atm	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500
2	Varian	INOVA	750

NMR Refinement
Method	Details	Software
torsion angle dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CNS	1.1	Brunger, A.T.
2	refinement	CNS	1.1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.